The pursuit of "remission" rather than just "management" is the new North Star for researchers in the field of CIDP. Advanced proteomics and genomic sequencing are allowing researchers to identify specific biomarkers that can predict a patient's response to various therapies. This shift toward precision medicine is reducing the "trial and error" phase of treatment, which is often frustrating...

Global economic fluctuations and shifting trade policies are casting a long shadow over the pharmaceutical supply chain. Companies are increasingly "friend-shoring" or "near-shoring" their outsourced services to mitigate the risks of geopolitical instability and logistics disruptions. This has led to a resurgence in service hubs within North America and Europe, even as Asia-Pacific remains a...